Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of TG Therapeutics, Inc.. A complete text table follows the diagram.
Product sales lead the therapeutic platform, with milestone and royalty revenue adding a smaller stream.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| TG Therapeutics revenue | 1 | $205M | $204.9M reported quarterly revenue |
| Product sales | 2 | $201M | 98% of total revenue |
| License, milestone, royalty and other | 2 | $3.6M | 2% of total revenue |
| From | To | Value |
|---|---|---|
| TG Therapeutics revenue | Product sales | $201M |
| TG Therapeutics revenue | License, milestone, royalty and other | $3.6M |